NEW DELHI: The drug pricing regulator has urged state governments to identify expensive and most commonly used drugs for diseases prevalent in their regions, which they think should be brought under price control in public interest.
This comes close on the heels of National Pharma Pricing Authority's (NPPA) plans to lower prices of expensive medicines used for select therapeutic categories such as cancer, HIV, diabetes, cardiovascular diseases, malaria and tuberculosis, as reported ..
This comes close on the heels of National Pharma Pricing Authority's (NPPA) plans to lower prices of expensive medicines used for select therapeutic categories such as cancer, HIV, diabetes, cardiovascular diseases, malaria and tuberculosis, as reported ..
No comments:
Post a Comment